Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.10%
March 31, 2026 -6.86%
December 31, 2025 -4.47%
September 30, 2025 -7.48%
June 30, 2025 -2.03%
March 31, 2025 -12.10%
December 31, 2024 -17.66%
September 30, 2024 -19.33%
June 30, 2024 -11.73%
March 31, 2024 -23.62%
December 31, 2023 -103.9%
September 30, 2023 -19.54%
June 30, 2023 -35.99%
March 31, 2023 -32.61%
December 31, 2022 -26.91%
September 30, 2022 -15.79%
June 30, 2022 -44.62%
March 31, 2022 -40.64%
December 31, 2021 -16.46%
September 30, 2021 -18.11%
June 30, 2021 -20.34%
March 31, 2021 -23.50%
December 31, 2020 -20.57%
September 30, 2020 4.10%
June 30, 2020 -13.96%
Date Value
March 31, 2020 7.10%
December 31, 2019 -1.29%
September 30, 2019 9.85%
June 30, 2019 1.46%
March 31, 2019 -1.72%
December 31, 2018 -8.31%
September 30, 2018 8.50%
June 30, 2018 10.57%
March 31, 2018 10.00%
December 31, 2017 6.75%
September 30, 2017 6.91%
August 31, 2016 -2.62%
May 31, 2016 -7.80%
February 29, 2016 10.43%
November 30, 2015 5.33%
August 31, 2015 10.59%
May 31, 2015 -2.46%
February 28, 2015 8.68%
November 30, 2014 3.49%
August 31, 2014 8.10%
May 31, 2014 6.00%
February 28, 2014 14.32%
November 30, 2013 7.43%
August 31, 2013 4.52%
May 31, 2013 3.91%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 19.20%
Abbott Laboratories 7.07%
AngioDynamics, Inc. -8.77%
Alphatec Holdings, Inc. -2.47%
AtriCure, Inc. 2.63%